SCD and obesity due to melanocortin 4 receptor deficiency: However, SCD1 inhibition has also been suggested to be a new therapeutic target for preventing type 2 diabetes itself, because SCD1 knockout mice showed resistance to HFD-induced obesity and insulin resistance [35].